FGF21 and steatosis: Baseline FGF21 was increased in subjects who developed simple steatosis during follow-up (309.79 pg/ml [169.11–506.43]) than those who did not (199.10 pg/ml [123.56–322.80], P < 0.001, Fig. 1a, Supplementary Table S2).